As Colorado becomes the second state to legalize psychedelic therapy this week, a clash is playing out in Colorado Springs, ...

From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

Last December, the FDA published its final guidance on predetermined change control plans, or PCCPs, with recommendations to ...

The Durham company, Ummino, is targeting the sharp rise in consumer demand for fortified food and beverage products. Its ...

In its overview of egg markets last week, the U.S. Department of Agriculture (USDA) said the California benchmark for large ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

In an era where digital screens dominate our daily lives, maintaining eye health has never been more critical. With ...

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...

The RELIEF ureteral stent, the brainchild of Dr. Lee Ponksy, chairman of UH’s Urology Institute, has been cleared by the U.S.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

House Bill 11 passed on April 11 and aims to curb the use of vaping among youth in Kentucky, but now retailers across the ...